Abound Wealth Management Ligand Pharmaceuticals Inc Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Abound Wealth Management holds 2 shares of LGND stock, worth $233. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$233% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
248Shares Held
17.7MCall Options Held
61KPut Options Held
7.8K-
Black Rock Inc. New York, NY2.87MShares$336 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$225 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$118 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3967KShares$113 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX707KShares$82.7 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.97B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...